Hormone Replacement Therapy Information & News

October 2, 2003
"Ovarian risk amongst combined Hormone Replacement Therapy users"

Women taking estrogen plus progestin were diagnosed as having invasive ovarian cancer at a rate of 42 per 100,000 person-years in comparison to the 15 per 100,000 person-years in the placebo group. The Hormone Replacement Therapy study analyzed trial data collected for the Women’s Health Initiative trial involving 16,608 postmenopausal women who had not had a hysterectomy at enrolment and were using a certain combination of Hormone Replacement Therapy drugs. Study authors concluded, “The possibility of an increased risk of ovarian cancer incidence and mortality remains worrisome.”

For more information on Hormone Replacement Therapy contact us to confer with a lawyer.

September 26, 2003
" Consumer group writes letter to FDA regarding Hormone Replacement Therapy safety concerns"

Public Citizen consumer group sent a letter to the FDA Commissioner because it felt there is incomplete, thus inaccurate information given to women on Hormone Replacement Therapy. The FDA had announced September 9, 2003 of the “Collaborative Campaign to Inform Women About Menopausal Hormone Therapy”, but according to the consumer group, a disservice was provided. The information failed to prominently display the black box warning, the strongest FDA issued warning of the links made between cancer and Premarin.

The letter went on to point out the contraindications to the use of Hormone Replacement Therapy is not displayed prominently and are instead displayed in a sidebar underneath a list of hormone benefits. There was also no mention of symptoms of Hormone Replacement Therapy illnesses or what to do if an illness occurs. The failure also to mention what alternatives to use in place of Hormone Replacement Therapy if using it simply to prevent osteoporosis has been left out.

The gaps of information in the website should not have been approved by the FDA simply based on the fact that omitting information mandated by the FDA by law. The consumer group urged the FDA to correct the information provided as soon as possible by replacing the Collaborative Campaign information with patient information based on the current FDA approved patient information for Premarin.

For more information on Hormone Replacement Therapy contact us to confer with a lawyer.

September 4, 2003
"Hormone Replacement Therapy news could end up being positive"

Women for decades have believed taking Hormone Replacement Therapy was the way to maintain youth and to promote health, but recent research has been showing the opposite. Instead, Hormone Replacement Therapy has been linked to higher risks of heart disease, breast cancer, ovarian cancer, and dementia. Since the WHI published the results of the Hormone Replacement Therapy in July 2002, the number of women using the drug has significantly decreased.

There were 3.4 million women using Prempro and by June 2003 just 1.2 million were still using it. Although the study had focused only on Prempro, the estrogen-progestin combination drug, the number of Premarin estrogen-only pill declined from 6.4 million to 4.5 million by July 2002. The results of the Premarin study will not be available until 2005.

Although the Hormone Replacement Therapy news had a potentially large impact considering millions of women using the drug therapy, some experts are seeing these findings in a different light. Now, more focus can be placed on menopause as a whole and promoting healthy lifestyles for women of all ages.

For more information on Hormone Replacement Therapy contact us to confer with a lawyer.

September 2003
"Hormone Replacement Therapy stance confusing to many women"

Ever since a July 2002 study indicated Hormone Replacement Therapy might be doing more harm than good, women have been confused about what to do ever since. The study was intended to be an eight-year process, as researchers enrolled 16,608 postmenopausal women at an average age of 63 to take Prempro or a placebo.

After just five years, researchers halted the study when a significant heart problem increase was seen to occur amongst the Prempro users. Women appear to have the largest risk of coronary artery problems during the first year of using Prempro, especially women with higher levels of low-density lipoprotein.

For more information on Hormone Replacement Therapy contact us to confer with a lawyer.

More Hormone Replacement Therapy News..

September 2003, "New Zealand Health Ministry to decide on Hormone Replacement Therapy"

Homepage • Side Effects of HRT • HRT Resources • About HRT • HRT Lawsuit
HRT Frequently Asked Questions • News • Site Map • Alternatives to HRT
Contact a Hormone Replacement Therapy Lawyer!